164 related articles for article (PubMed ID: 10423048)
21. Factor analysis of laboratory and clinical measurements of dyspnea in patients with chronic obstructive pulmonary disease.
Nguyen HQ; Altinger J; Carrieri-Kohlman V; Gormley JM; Stulbarg MS
J Pain Symptom Manage; 2003 Feb; 25(2):118-27. PubMed ID: 12590027
[TBL] [Abstract][Full Text] [Related]
22. Comparison of discriminative properties among disease-specific questionnaires for measuring health-related quality of life in patients with chronic obstructive pulmonary disease.
Hajiro T; Nishimura K; Tsukino M; Ikeda A; Koyama H; Izumi T
Am J Respir Crit Care Med; 1998 Mar; 157(3 Pt 1):785-90. PubMed ID: 9517591
[TBL] [Abstract][Full Text] [Related]
23. Clinical utility of measures of breathlessness.
Cullen DL; Rodak B
Respir Care; 2002 Sep; 47(9):986-93. PubMed ID: 12188932
[TBL] [Abstract][Full Text] [Related]
24. Validity of a Self-administered Questionnaire Version of the Transition Dyspnea Index in Patients with COPD.
von Leupoldt A; Reijnders T; Schuler M; Wittmann M; Jelusic D; Schultz K
COPD; 2017 Feb; 14(1):66-71. PubMed ID: 27841688
[TBL] [Abstract][Full Text] [Related]
25. The psychologic consequences of chronic dyspnea in chronic pulmonary obstruction disease: the effects of acupressure on depression.
Wu HS; Lin LC; Wu SC; Lin JG
J Altern Complement Med; 2007 Mar; 13(2):253-61. PubMed ID: 17388769
[TBL] [Abstract][Full Text] [Related]
26. Acceptability and accuracy of patient-reported outcome measures (PROMs) for surveillance of breathlessness in routine lung cancer care: A mixed-method study.
Sung JH; Brown MC; Perez-Cosio A; Pratt L; Houad J; Liang M; Gill G; Moradian S; Liu G; Howell D
Lung Cancer; 2020 Sep; 147():1-11. PubMed ID: 32634651
[TBL] [Abstract][Full Text] [Related]
27. Dyspnea scales in the assessment of illiterate patients with chronic obstructive pulmonary disease.
Martinez JA; Straccia L; Sobrani E; Silva GA; Vianna EO; Filho JT
Am J Med Sci; 2000 Oct; 320(4):240-3. PubMed ID: 11061348
[TBL] [Abstract][Full Text] [Related]
28. Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung Study.
Khanna D; Clements PJ; Furst DE; Chon Y; Elashoff R; Roth MD; Sterz MG; Chung J; FitzGerald JD; Seibold JR; Varga J; Theodore A; Wigley FM; Silver RM; Steen VD; Mayes MD; Connolly MK; Fessler BJ; Rothfield NF; Mubarak K; Molitor J; Tashkin DP;
Arthritis Rheum; 2005 Feb; 52(2):592-600. PubMed ID: 15692967
[TBL] [Abstract][Full Text] [Related]
29. Dyspnea in cancer patients.
Drings P
Support Care Cancer; 1999 Jul; 7(4):215-6. PubMed ID: 10423043
[No Abstract] [Full Text] [Related]
30. [Validation study of the BDI/TDI scores in chronic obstructive pulmonary disease].
Laurendeau C; Pribil C; Perez T; Roche N; Simeoni MC; Detournay B
Rev Mal Respir; 2009 Sep; 26(7):735-43. PubMed ID: 19953015
[TBL] [Abstract][Full Text] [Related]
31. Dyspnea scales as a measure of health-related quality of life in patients with idiopathic pulmonary fibrosis.
Baddini Martinez JA; Martinez TY; Lovetro Galhardo FP; de Castro Pereira CA
Med Sci Monit; 2002 Jun; 8(6):CR405-10. PubMed ID: 12070430
[TBL] [Abstract][Full Text] [Related]
32. Usefulness of the culturally adapted oxygen-cost diagram in the assessment of dyspnea in Puerto Rico.
De Jesús-Berrios Y; Santos-Rodríguez RA; Dexter D; Nieves-Plaza M; Nazario CM
P R Health Sci J; 2015 Mar; 34(1):14-9. PubMed ID: 25856872
[TBL] [Abstract][Full Text] [Related]
33. Adaptation of the Medical Research Council Dyspnea Scale and the Oxygen Cost Diagram for its use in Puerto Rico.
Serrano J; De Jesús-Berríos Y; Santos RA; Dexter D; Nazario CM; Montalvo F
P R Health Sci J; 2007 Jun; 26(2):135-40. PubMed ID: 17722426
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of clinical methods for rating dyspnea.
Mahler DA; Wells CK
Chest; 1988 Mar; 93(3):580-6. PubMed ID: 3342669
[TBL] [Abstract][Full Text] [Related]
35. A comparison of the level of dyspnea vs disease severity in indicating the health-related quality of life of patients with COPD.
Hajiro T; Nishimura K; Tsukino M; Ikeda A; Oga T; Izumi T
Chest; 1999 Dec; 116(6):1632-7. PubMed ID: 10593787
[TBL] [Abstract][Full Text] [Related]
36. Assessment of the psychometric properties of an English version of the cancer dyspnea scale in people with advanced lung cancer.
Uronis HE; Shelby RA; Currow DC; Ahmedzai SH; Bosworth HB; Coan A; Abernethy AP
J Pain Symptom Manage; 2012 Nov; 44(5):741-9. PubMed ID: 22765966
[TBL] [Abstract][Full Text] [Related]
37. Breathlessness, functional status, distress, and palliative care needs over time in patients with advanced chronic obstructive pulmonary disease or lung cancer: a cohort study.
Weingaertner V; Scheve C; Gerdes V; Schwarz-Eywill M; Prenzel R; Bausewein C; Higginson IJ; Voltz R; Herich L; Simon ST; ;
J Pain Symptom Manage; 2014 Oct; 48(4):569-81.e1. PubMed ID: 24613784
[TBL] [Abstract][Full Text] [Related]
38. Measurement of breathlessness in clinical trials in patients with chronic heart failure: the need for a standardized approach: a systematic review.
Johnson MJ; Oxberry SG; Cleland JG; Clark AL
Eur J Heart Fail; 2010 Feb; 12(2):137-47. PubMed ID: 20083623
[TBL] [Abstract][Full Text] [Related]
39. Which measurement scales should we use to measure breathlessness in palliative care? A systematic review.
Dorman S; Byrne A; Edwards A
Palliat Med; 2007 Apr; 21(3):177-91. PubMed ID: 17363394
[TBL] [Abstract][Full Text] [Related]
40. Functional status and quality of life in chronic obstructive pulmonary disease.
Reardon JZ; Lareau SC; ZuWallack R
Am J Med; 2006 Oct; 119(10 Suppl 1):32-7. PubMed ID: 16996897
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
